Citrullinated histone H3 as a novel prognostic blood marker in patients with advanced cancer

Thålin, C., Lundström, S., Seignez, C. et al. (7 more authors) (2018) Citrullinated histone H3 as a novel prognostic blood marker in patients with advanced cancer. PLoS ONE, 13 (1). e0191231. ISSN 1932-6203

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2018 Thålin et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Dates:
  • Accepted: 29 December 2017
  • Published (online): 11 January 2018
  • Published: 11 January 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Oncology (Sheffield)
The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Human Communication Sciences (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 08 Apr 2020 14:41
Last Modified: 08 Apr 2020 14:41
Status: Published
Publisher: Public Library of Science (PLoS)
Refereed: Yes
Identification Number: https://doi.org/10.1371/journal.pone.0191231
Related URLs:

Export

Statistics